For Second Time in Three Years, OPKO Health Will Acquire a Clinical Laboratory Company by Spending $1.47 Billion to Acquire Bio-Reference Laboratories

When completed, this acquisition means that the third largest public lab company in the United States will be owned by a multinational biopharmaceutical and diagnostics firm It’s a big medical laboratory acquisition that has some experts on Wall Street shaking their heads. Last Thursday, it was announced that OPKO Health Inc. of Miami, Florida, would pay $1.47 billion to acquire Bio-Reference Laboratories Inc. (NASDAQ: BRLI), the nation’s third largest full-service clinical laboratory. OPKO...

New Handheld HIV Testing Device is Faster and Cheaper than ELISA Tests Performed in Clinical Pathology Laboratories

Goal is to deliver more accurate medical laboratory testing in developing countries to improve quality of care Picture a point-of-care (POC) device that produces highly accurate HIV results at a lower cost and 10 times faster than traditional ELISA testing currently done by clinical laboratories—then automatically, instantaneously transmits and synchronizes the results with cloud-based electronic healthcare records. This device is a reality and was developed by researchers at Columbia...
;